Ocugen Inc at Chardan Genetic Medicines Conference Transcript
Good morning, everyone. Thank you for attending the Chardan Sixth Annual Genetic Medicines Conference. My name is Daniil Gatualin. I'm one of the senior biotech analysts here at Chardon It is my pleasure to welcome our next guest from Ocugen. We have Dr. Shankar Musunuri, Chairman and CEO.
This session will follow a fireside chat, but we always encourage the members of the audience to jump in with questions. And with that, I think we will go ahead and get started.
Questions & Answers
So, Shankar, to begin, can you spend a few minutes and provide an overview of the company and the high level of the recent highlights?
Yes. Thank you, first of all, for having me this morning. Then Ocugen, we are focused -- patient-centric biotech company focused on vaccines for public health, gene and cell therapies, targeting unmet medical needs through
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |